OLNOLIN Corp
Chemicals & Allied Products
- Revenue
- $6.8B
- 3.7% YoY
- Operating margin
- 0.1%
- 98% YoY
- EBITDA
- $527M
- 35% YoY
- Market cap
- —
- Employees
- —
- Net debt / EBITDA
- 5.4×
- $2.8B net debt
- AI in 10-K
- —
Red flags 0 of 9
- TSR below peersClear—3+ of last 5 years
- High CEO pay despite TSRClear—Median CEO pay ≥ $15M and TSR flag
- Active 13DClear0 filingsActive-intent 13D in 18 months
- Net insider sellingClear$0 netNet sales over $10M in 12 months
- Earnings not backed by cashClear—Cash flow under 80% of net income
- Dilutive SBCClear0% of revenueOver 10% of revenue
- Payouts exceed cash flowClear30% of cash flowBuybacks + dividends over cash flow
- Goodwill-heavyClear19% of assetsOver 40% of assets
- Shareholder dissentClear—Any vote under 80% support
Financials
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | YoY |
|---|---|---|---|---|---|---|
| Revenue | $8.9B | $9.4B | $6.8B | $6.5B | $6.8B | 3.7% |
| Operating income | $1.9B | $1.8B | $712M | $297M | $5M | 98% |
| Net income | $1.3B | $1.3B | $452M | $105M | −$101M | 196% |
| Operating cash flow | $1.7B | $1.9B | $974M | $503M | $474M | 5.8% |
| Capex | $201M | $237M | $236M | $195M | $226M | 16% |
| Stock-based comp | $8M | $14M | $19M | $17M | $21M | 21% |
| Buybacks | $252M | $1.4B | $711M | $300M | $51M | 83% |
| Dividends | $128M | $116M | $101M | $94M | $92M | 2.8% |
Deal filings
None.
13D filers
None on file.
Insider trading
No open-market trades in the last 12 months.
Pay vs performance
No pay-versus-performance disclosure yet.